| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/14/2004 | US20040204578 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 10/14/2004 | US20040204574 TSA305 gene |
| 10/14/2004 | US20040204568 Comprises nucleotide sequences coding cell adhesion molecules for use in the diagnosis, prevention and treatment of autoimmune and cell proliferative disorders |
| 10/14/2004 | US20040204565 Use of multivalent chimeric peptide-loaded, MHC/IG molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 10/14/2004 | US20040204564 CRFR1 selective ligands |
| 10/14/2004 | US20040204563 Generating transgenic bacteria coding/expressing eschrichia thioredoxin fusion protein for use as diagnostic marker in heterologous gene expression; bioreactors |
| 10/14/2004 | US20040204562 Polynucleotides encoding cytokine receptor zalpha11 |
| 10/14/2004 | US20040204420 Compounds for modulating RNA interference |
| 10/14/2004 | US20040204388 incubating SV2 protein or fragment with levetiracetam or an analog or derivative thereof and a potential binding partner and determining if the potential binding partner modulates the binding of levetiracetam to the SV2 protein |
| 10/14/2004 | US20040204380 NUCLEOTIDE SEQUENCES FOR USE IN THE TREATMENT OF cancer, chondrodysplasia; BIODRUG, MODIFIED NUCLEOTIDES |
| 10/14/2004 | US20040204377 delivering an siRNA or engineered RNA precursor to a cell by conjugating at least one delivery peptide to an siRNA or engineered RNA precursor, thereby forming a peptide-conjugate, and contacting the cell with the peptide-conjugate; nontoxic |
| 10/14/2004 | US20040204376 Focal calcium channel modulation |
| 10/14/2004 | US20040204373 compound of 8 to 50 nucleobases in length targeted to nucleic acid molecule encoding Histone deacetylase 1, where compound specifically hybridizes with and inhibits expression of Histone deacetylase 1; use in treating animal having disease or condition associated with Histone deacetylase 1 such as cancer |
| 10/14/2004 | US20040204361 Kdel receptor inhibitors |
| 10/14/2004 | US20040204352 a novel protein (INSP052), identified as an immunoglobulin domain-containing cell surface recognition molecule and to the use of this proteins and nucleic acid sequences from the encoding gene in the diagnosis, prevention and treatment of disease |
| 10/14/2004 | US20040204350 Disease- associated protein |
| 10/14/2004 | US20040204349 Inducing cytotoxicity in a neoplastic cell comprising: contacting said cell with an amount of a GSSP-2 polypeptide |
| 10/14/2004 | US20040204345 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 10/14/2004 | US20040204338 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action |
| 10/14/2004 | US20040203158 Transposon-insulator element delivery systems |
| 10/14/2004 | US20040203157 Transfroming arabidopsis with expression vector coding genes associated with heat, freeze, salt and drought resistance; using ribonucleoproteins to control effivient gene transcription in plants; bioreactors |
| 10/14/2004 | US20040203156 Transgenic cell comprising sequences coding viral envelope protein for use as bioreactors in genetic engineering |
| 10/14/2004 | US20040203155 Methods for transfecting T cells |
| 10/14/2004 | US20040203154 Process for generating multilayered particles |
| 10/14/2004 | US20040203153 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made |
| 10/14/2004 | US20040203152 Using serine recombinase as nucleotide sequence insertional tool for generating transgenic cells, tissues or plants; site specific recombination and gene therapy |
| 10/14/2004 | US20040203146 Composite scaffolds and methods using same for generating complex tissue grafts |
| 10/14/2004 | US20040203144 Using calcium-activated chloride channels (CLCA) to identify modulators for treatment of bronchitis, asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and bronchiectasis |
| 10/14/2004 | US20040203141 Use of the AP1 gene promoter to control the vernalization response and flowering time in grasses |
| 10/14/2004 | US20040203133 Helper dependent adenoviral vector system and methods for using the same |
| 10/14/2004 | US20040203130 Subtilisin variants |
| 10/14/2004 | US20040203129 having high specific activity and strong oxidant resistance, and having excellent detergency that is to be added to a detergent |
| 10/14/2004 | US20040203128 Use of PP2A phosphatase modulators in the treatment of mental disorders |
| 10/14/2004 | US20040203126 without involving fluid movements using gel partition and electrophoresis/magnetopohoresis |
| 10/14/2004 | US20040203125 recombinant chimera produced using solid phase synthesis; for biosnesors/bioreactors, diagnostic and drugs |
| 10/14/2004 | US20040203124 Electrodes coated with treating agent and uses thereof |
| 10/14/2004 | US20040203123 Method for transforming Amycolatopsis sp. DSM 9991 and DSM 9992 |
| 10/14/2004 | US20040203119 synthase (PKS) system, comprising at least two modules, of said PKS, wherein said PKS has been modified to prevent its utilization of its native starter unit, but wherein said PKS is able to incorporate a diketide substrate into a polyketide that is at least a triketide |
| 10/14/2004 | US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene |
| 10/14/2004 | US20040203117 Method of expressing genetically modified protein carrying sugar chain having sialic acid added thereto in insect cells |
| 10/14/2004 | US20040203116 IL-1 eta DNA and polypeptides |
| 10/14/2004 | US20040203115 Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb) |
| 10/14/2004 | US20040203113 Nucleic acids encoding beta 1,4-N-acetylgalactosaminyltransferases from C. jejuni |
| 10/14/2004 | US20040203112 Beta1,4-N-acetylgalactosaminyltransferases from C. jenuni |
| 10/14/2004 | US20040203111 UDP-N-acetylglucosamine: galactose-B1,3-N-acetylgalactosamine-a-R/ (GlcNAc to GalNAc) B1-6 N- acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203107 Methods and compositions for grafting functional loops into a protein |
| 10/14/2004 | US20040203105 for drug screening emzyme inhibitors using genetically engineered animal models; for anticancer agents |
| 10/14/2004 | US20040203104 for drug screening enzyme inhibitors; genetic engineering; comprising subjecting the sample to a polymerase chain reaction, a northern hybridization assay or an in situ hybridization assay |
| 10/14/2004 | US20040203103 has both an alpha 2,3- and an alpha 2,8-activity; involved in synthesis of lipooligosaccharide (LOS); genetic engineering |
| 10/14/2004 | US20040203100 provides a family of antibodies that specifically bind the human cell surface glycosphingolipid GD2 for treating cancer by administering in vitro; genetic engineering |
| 10/14/2004 | US20040203099 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 10/14/2004 | US20040203098 Compounds and methods for modulating activation of NF-kappaB |
| 10/14/2004 | US20040203097 Kinases and phosphatases |
| 10/14/2004 | US20040203095 from porcine pancreas in pichia pastoris which is soluble and secreted into the culture medium, whereby expression at pH 3.0-4.0 substantially prevents activation of trypsinogen to beta -trypsin and autolysis of beta-trypsin by alpha -trypsin |
| 10/14/2004 | US20040203093 Nucleotide sequence of the haemophilus influenzae rd genome, fragments thereof, and uses thereof |
| 10/14/2004 | US20040203092 UDP-N-acetylglucosamine:galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203091 Process for synthesizing protein using cell-free protein synthesis system |
| 10/14/2004 | US20040203087 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout |
| 10/14/2004 | US20040203080 7 transmembrane receptor family member BLRx |
| 10/14/2004 | US20040203073 Adenosine triphosphate (ATP)-binding cassette gene (ABC7), polypeptide and methods of detecting mutations therein; kits |
| 10/14/2004 | US20040203066 Identifying modulator of progression elevated gene-3 (PEG-3) for use in treatment and prevention of antitumor/antiproliferative/antisense agents; peptide mimetic |
| 10/14/2004 | US20040203064 Using expressed sequence tags to correlate gene expression profiles with stress/disease phenotypes |
| 10/14/2004 | US20040203061 Using primer mismatches to identify and amplify polymorphic target gene sequences; mutational analysis; multiplex detection of nucleic acid sequence differences |
| 10/14/2004 | US20040203059 Novel human proteases and polynucleotides encoding the same |
| 10/14/2004 | US20040203057 Novel DNA cloning method |
| 10/14/2004 | US20040203056 Chemical amplification for the synthesis of patterned arrays |
| 10/14/2004 | US20040203053 Blackcurrant promoters and genes |
| 10/14/2004 | US20040203051 Nucleotide sequences coding two or more tumor associated antigens for use in identify modulators of major histocompatibility complex; preventing infections |
| 10/14/2004 | US20040203046 Methods for modulating cellular and organismal phenotypes |
| 10/14/2004 | US20040203040 can be effectively and stably immobilized on the substrate, containing an organic solvent, and a substance for solubilizing the probe in the organic solvent; solid phase synthesis |
| 10/14/2004 | US20040203039 Attenuated salmonella SP12 mutants as antigen carriers |
| 10/14/2004 | US20040203038 Process for preparing novel cyanine dye labeling reagents |
| 10/14/2004 | US20040203029 Method for the specific fast detection of threadlike bacteria |
| 10/14/2004 | US20040203021 functional to a yeast site-specific flippase recombinase (FLP); for occurring a local and imprecise transposition; for drug screening; genetic engineering |
| 10/14/2004 | US20040203020 Self-replicating RNA molecule from hepatitis C virus |
| 10/14/2004 | US20040203019 Methods and compositions for transcription-based nucleic acid amplification |
| 10/14/2004 | US20040203017 utilize the abilities to over and/or under express the product in a cell, as well as the combination of these results, to permit the identification of at least one of the product's cellular or in vivo functionality |
| 10/14/2004 | US20040203016 Rapid subcloning using site-specific recombination |
| 10/14/2004 | US20040203015 comprises cell which produces megosamine and can attach megosamine to a polyketide; includes genes of the mycarosyl/desosamine biosynthesis pathway and transferase |
| 10/14/2004 | US20040203014 Neurotransmisson-associated proteins |
| 10/14/2004 | US20040203013 Plant system for comprehensive gene function analysis with the use of full-length cdna |
| 10/14/2004 | US20040203003 comprising isolating messenger RNA and performing reverse transcription polymerase chain reaction (PCR) and assessing the concentrations of the resulting amplicons; genetic engineering |
| 10/14/2004 | US20040203001 Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereof |
| 10/14/2004 | US20040202999 for drug screening treatments for human immunodeficiency virus (HIV), cancer; gene therapy; long terminal repeat sequences; genetic engineering |
| 10/14/2004 | US20040202998 Method of amplifying or detecting HIV-1 RNA |
| 10/14/2004 | US20040202997 by a combination of nucleic acid amplification and molecular weight determination using primers which bracket variable sequence regions that uniquely identify a base composition signature (BCS) |
| 10/14/2004 | US20040202995 variable region polypeptides fused at their N-terminus to a bacterial signal sequence; providing an efficient way to select small antibody fragments that are labeled and that have high affinity to target ligand |
| 10/14/2004 | US20040202761 Cocoa flavor precursor peptides |
| 10/14/2004 | US20040202679 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 10/14/2004 | US20040202678 attenuated, having a mutation in a gene encoding a repeat in toxin |
| 10/14/2004 | US20040202674 zona pellucida polypeptide, and/or a variant, from a carnivorous mammal, useful in reducing fertility of cats and/or dogs. |
| 10/14/2004 | US20040202667 also use in the development of antimalarial drugs and antibodies directed against these Plasmodium proteins. |
| 10/14/2004 | US20040202663 Therapy for primary and metastatic cancers |
| 10/14/2004 | US20040202662 Humanised antibodies |
| 10/14/2004 | US20040202661 a peptide or derivative capable of binding to the IL-2 beta chain or the monoclonal antibodies produced by H2-8 hybridoma; induces SHC phosphorylation or induces the SHC/MAPK pathway |
| 10/14/2004 | US20040202659 A polypeptide encoded by a nucleic acid that encodes a heavy chain, which is able to bind to GPIIb/IIIa, of a human antibody and comprising a CDR3 region; diagnosis, treatment or prevention of autoimmune thrombocytopenic purpura; modulating blood coagulation |
| 10/14/2004 | US20040202657 Humanized anti-CD3 specific antibodies |
| 10/14/2004 | US20040202655 antibody or antigen binding portion thereof that specifically binds to IGF-IR, administered for tumor or cancer treatment; also a nucleic acid molecule that comprises sequence that encodes the antibody or fragment |
| 10/14/2004 | US20040202654 gp100-derived polypeptides that contain both a helper T-cell epitope and a cytotoxic T-cell epitope used to induce antitumor responses in melanoma patients |
| 10/14/2004 | US20040202650 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |